United States News Todas as matérias

Li Auto (NASDAQ:LI) delivered 31,817 vehicles in September 2026, with cumulative deliveries reaching 1,833,651 vehicles as the company expanded its battery-electric vehicle lineup.

Tigo Energy (NASDAQ:TYGO) announced it will showcase its GO Optimized Energy Storage Solution at Smart Energy Forum 2026 in Prague, following increased deployment of its solar technology across the Czech market.

NIO (NYSE:NIO) delivered 37,408 vehicles in September 2026, representing a 7.7% year-over-year increase across its NIO, ONVO and FIREFLY vehicle brands.

Regeneron (NASDAQ:REGN) expanded its antibody alliance with Sanofi through an agreement covering four long-acting antibody candidates and a $1 billion upfront payment to Regeneron.

XPENG (NYSE:XPEV) delivered 41,256 vehicles in September 2026, with monthly deliveries increasing 5% compared with the previous month and third-quarter deliveries reaching 118,390 vehicles.

Oculis (NASDAQ:OCS) joined the National Multiple Sclerosis Society’s Campaign to End MS as an industry partner focused on advancing research and care related to vision problems in multiple sclerosis.

ADS-TEC Energy (NASDAQ:ADSE) reported unaudited first-half 2026 revenue of €7.4 million for the six months ended June 30, 2026, compared with €14.6 million in the prior-year period.

Ares Management (NYSE:ARES) announced that its Ares Alternative Credit funds participated in a Plenitude ownership and governance restructuring, increasing its stake after a combined capital contribution of approximately €1.5 billion with Eni.

Pfizer (NYSE:PFE) reported Phase 2 results showing that investigational tilrekimig achieved its primary endpoint by producing statistically significant increases in EASI-75 responses compared with placebo at Week 16 in adults with moderate-to-severe atopic dermatitis.

Inseego (NASDAQ:INSG) completed its acquisition of Nokia’s (NYSE:NOK) fixed wireless access business, expanding its wireless broadband operations across Europe, the Middle East, Asia, Oceania and the Americas.

United Therapeutics (NASDAQ:UTHR) shares rose 13% to $543.99 after a Delaware federal court denied Liquidia’s motion to strike a defense argument in a patent infringement case involving Tyvaso and Yutrepia.

Tiziana Life Sciences (NASDAQ:TLSA) submitted a request to the U.S. Food and Drug Administration for Orphan Drug Designation for intranasal foralumab as a potential treatment for multiple system atrophy (MSA).

Kailera Therapeutics (NASDAQ:KLRA) announced completion of enrollment across three global Phase 3 trials evaluating investigational once-weekly ribupatide injection in people with obesity or overweight.

Jade Biosciences (NASDAQ:JBIO) reported preclinical results for JADE301, an investigational antibody targeting dermatomyositis, at the European Academy of Dermatology and Venereology Congress in Vienna.

Connect Biopharma (NASDAQ:CNTB) reported preliminary Phase 2 results showing that investigational rademikibart reduced treatment failure in adults with acute chronic obstructive pulmonary disease (COPD) exacerbations and type 2 inflammation.

NRx Pharmaceuticals (NASDAQ:NRXP) announced that its subsidiary NRx Defense Systems received an initial DARPA prime contract worth $11,177,757.27 to evaluate a treatment approach for major depressive disorder.

Atara Biotherapeutics (NASDAQ:ATRA) announced that partner Pierre Fabre Pharmaceuticals resubmitted the Biologics License Application (BLA) for tabelecleucel to the U.S. Food and Drug Administration for treatment of relapsed or refractory EBV-positive post-transplant lymphoproliferative disease.

Cerenome (NASDAQ:CNSY) reported unaudited third-quarter 2026 gross payer billings of $1.55 million from 222 tests performed by its wholly owned CNSide Diagnostics subsidiary.

KIDZ AI (NASDAQ:KIDZ) submitted a procurement inquiry to Tesla for an initial 500 Robotaxis as part of a preliminary plan to explore an autonomous vehicle fleet strategy.

RedCloud (NASDAQ:RCT) reported revenue of $24 million for the six months ended June 30, 2026, an increase of 34% year over year, as total trading volume increased to $1.56 billion.

Ten-League International Holdings (NASDAQ:TLIH) reported unaudited first-half 2026 revenue of S$33.1 million for the six months ended June 30, 2026, with revenue declining as equipment and parts sales decreased.

Rich Sparkle Holdings (NASDAQ:ANPA) reported unaudited revenue of US$2.12 million for the six months ended March 31, 2026, representing a 21.8% increase compared with the prior-year period.

Sarepta Therapeutics (NASDAQ:SRPT) presented new clinical data showing ELEVIDYS (delandistrogene moxeparvovec) was associated with functional benefits in older ambulatory patients with Duchenne muscular dystrophy at the World Muscle Society Congress 2026.

Recon Technology (NASDAQ:RCON) reported fiscal 2026 revenue of RMB109.9 million for the year ended June 30, 2026, an increase of 65.8% from the prior fiscal year.